Prosecution Insights
Last updated: November 04, 2026
Application No. 18/276,835

Dental Apparatus with Antimicrobial Activity

Non-Final OA §102§112
Filed
Aug 10, 2023
Priority
Feb 12, 2021 — BE 2021/5102 +1 more
Examiner
NELSON, MATTHEW M
Art Unit
3772
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Zinkh NV
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
0m
Est. Remaining
82%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
513 granted / 884 resolved
-12.0% vs TC avg
Strong +24% interview lift
Without
With
+23.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
55 currently pending
Career history
943
Total Applications
across all art units

Statute-Specific Performance

§101
3.7%
-36.3% vs TC avg
§103
45.3%
+5.3% vs TC avg
§102
21.5%
-18.5% vs TC avg
§112
23.8%
-16.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 884 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of group I (claims 1-9, 13-18) in the reply filed on 8/24/2026 is acknowledged. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-9, 13-18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites “at a concentration of between 0.001% and 10%”, however it has not been stated whether this is by weight or volume. Claims 2-3 and 16-18 discuss what concentration of metal ions is released. Again, there is the issue of by weight or volume. Further, these claims are unclear as they are missing a time period of when this concentration loss is measured. The application discusses exposure for 24 hours, or at least 36 hours, as a possible exposure time. Claims 9 and 14 discuss the intended use of the apparatus, however it has already been established to be a dental apparatus and is a size that can fit in the oral cavity, so it is unclear what claims 9 and 14 are adding by the recited intended use. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-9, 13-18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Barry et al. (US 6,267,590). Barry shows a dental apparatus (such as a bracket in Fig. 1 or col. 2, lines 11-13), wherein the apparatus is made of a polymer composition (col. 3, lines 32-52) having antimicrobial activity (col. 3, lines 32-60), wherein the polymer composition comprises one or more metal ions and/or metal salts at a concentration of between 0.001% and 10% (see 112 above; col. 3, lines 23-27; col. 3, near line 41). With respect to claim 2, wherein the released concentration of the metal ions when using the apparatus in the oral cavity of a patient is up to a maximum of 21 ppm (see 112 above, however Barry shows in end of col. 1 to col. 2 that the appliances do not have to be replaced to maintain antimicrobial action and therefore would necessarily have a low released concentration, particularly over short periods of time). With respect to claims 3, and 16-18, these are addressed similarly to claim 2. With respect to claim 4, characterized in that the metal ions and/or salts of said metal ions are dispersed or dissolved in the polymer composition (Summary of Invention discusses the agent mixed with the resin and therefore dispersed). With respect to claim 5, wherein the metal ion is selected from the group consisting of Al (aluminum), Si (silicon), Ti (titanium), V (vanadium), Cr (chromium), Mn (manganese), Co (cobalt), Ni (nickel), Cu (copper), Zn (zinc), Zr (zirconium), Nb (niobium), Mo (molybdenum), Pd (palladium), Ag (silver), Sn (tin), Se (selenium), Ta (tantalum), W (tungsten), Pb (lead), Au (gold), Pt (platinum) or a combination of these (Silver ions; see Summary of Invention). With respect to claim 6, wherein the metal ion is zinc and wherein zinc is present in the polymer composition in the form of a zinc salt (col. 8 discusses antimicrobial selection of zinc and that the metal salts of the various metals are used). With respect to claim 7, wherein the polymer composition consists of one or more polymers selected from acrylates and methacrylates, polyesters, thermoplastic polyurethanes (TPU), polyether blockamides (PEBAX), polyolefinsand polyolefin copolymers, styrene-based thermoplastics, polyamides, polycarbonate (PC) and polyacetals, silicones or a mixture thereof (middle of col. 3 discusses acrylic [acrylate]). With respect to claim 8, wherein the apparatus comprises orthodontic braces, a sports mouthguard, a gingivitis mouthguard, an orthodontic aligner, a temporary crown, a permanent crown, a bite plate, dentures, an antibacterial pad, a palatal splint, an anti-snoring device, a whitening shield, a bruxism splint, a coping, a fluoride shield, an individual impression tray, a Michigan splint, a medication shield, a radiation shielding splint, an occlusal splint, an interim prosthesis, or a similar device (braces as pictured). With respect to claim 9, for use in the prevention or treatment of bacterial oral diseases (see 112 above, however due to it being antimicrobial, it will fulfill this intended use). With respect to claim 13, wherein the acrylates and methacrylates are chosen from polymethyl acrylate (PMA) or polymethyl methacrylate (PMMA)[[)]]; wherein the polyesters are chosen from polyethylene terephthalate (PET), polyethylene terephthalate glycol (PETG), polycaprolactone (PCL), polysulfone (PSU), polylactic acid (PLA), poly(lactic-co-glycolic acid) (PLGA), polybutylene terephthalate (PBT), polyethylene furanoate (PEF), polypropylene terephthalate (PPT), polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), or polybutylene succinate adipate (PBSA); wherein the polyolefins and polyolefin copolymers are chosen from polyethylene (PE), polypropylene (PP), ethylene vinyl acetate (EVA), polyvinyl butyraldehyde (PVB), polybutylene (PB), polyisobutylene (PIB), or ethylene propylene diene monomer (EPDM); wherein the styrene-based thermoplastics are chosen from poly(styrene-butadiene-styrene) (SBS), polystyrene, acrylonitrile butadiene styrene (ABS), acrylonitrile styrene acrylate (ASA), or styrene acrylonitrile (SAN); wherein the polyamides are chosen from polyamide 6, polyamide 6,6 or polyamide 12; and wherein the polyacetals are polyoxymethylene (POM) (col. 5, lines 36-46 for instance discuss the use of polyethylene PE). With respect to claim 14, wherein the bacterial oral disease is gingivitis, periodontitis or halitosis (see 112 above; similarly to claim 8, this is considered intended use that would be accomplished by antimicrobial agents). With respect to claim 15, wherein the zinc salt is zinc PCA, zinc oxide, zinc hydroxide, zinc pyrrolidone, zinc pyrithione, a zinc salt of a fatty acid or a mixture thereof (col. 9, lines 43-52 discuss the metal ions including their oxides/salts/etc; see also col. 8 discussing the metal ion salts). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATTHEW NELSON whose telephone number is (571)270-5898. The examiner can normally be reached on Monday-Friday 7:30am-5:00pm EDT. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Eric Rosen, at (571) 270-7855. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MATTHEW M NELSON/Primary Examiner, Art Unit 3772
Read full office action

Prosecution Timeline

Aug 10, 2023
Application Filed
Oct 28, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778730
CURING SYSTEM AND METHOD
2y 9m to grant Granted Nov 03, 2026
Patent 12778732
Teeth Whitening System
2y 1m to grant Granted Nov 03, 2026
Patent 12773300
Dental Connection Assembly, Dental Replacement Part Kit and Intermediate Insert
3y 8m to grant Granted Oct 27, 2026
Patent 12758361
Method for Generating Design of Orthodontic Appliance
1y 11m to grant Granted Oct 13, 2026
Patent 12740833
PATIENT SPECIFIC DYNAMIC NAVIGATION TRACKER ARM MOUNT APPARATUS AND METHOD
4y 11m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
82%
With Interview (+23.8%)
3y 3m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 884 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month